CAPTRUST FINANCIAL ADVISORS - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$36,000
-16.3%
2,597
+17.4%
0.00%
Q1 2022$43,0000.0%2,213
-16.9%
0.00%
Q4 2021$43,000
-17.3%
2,662
+42.0%
0.00%
Q3 2021$52,000
-7.1%
1,8740.0%0.00%
-100.0%
Q2 2021$56,000
-15.2%
1,874
-21.1%
0.00%0.0%
Q1 2021$66,000
+34.7%
2,374
+36.3%
0.00%0.0%
Q4 2020$49,000
+11.4%
1,7420.0%0.00%0.0%
Q3 2020$44,0000.0%1,7420.0%0.00%0.0%
Q2 2020$44,000
+1366.7%
1,742
+771.0%
0.00%
Q3 2019$3,0000.0%2000.0%0.00%
Q2 2019$3,0000.0%2000.0%0.00%
Q1 2019$3,000
-25.0%
2000.0%0.00%
Q4 2018$4,000
-20.0%
2000.0%0.00%
Q3 2018$5,0000.0%2000.0%0.00%
Q2 2018$5,000
-16.7%
2000.0%0.00%
Q1 2018$6,000
-14.3%
2000.0%0.00%
Q4 2017$7,000
+16.7%
2000.0%0.00%
Q3 2017$6,0002000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders